Literature DB >> 2458182

The altered expression of MHC-class II determinants on monocytes of cancer patients.

W Uracz1, J Stachura, A Pituch-Noworolska, T Popiela, A Czupryna, M Zembala.   

Abstract

The expression of MHC class II determinants Ia.7 (detected by cross reactive mouse anti-Iak antibody) and HLA-DR on monocytes (MO) of gastric and colorectal cancer patients was examined. An increased proportion of MO bearing the Ia.7 determinant was found, while the number of MO expressing DR was not elevated. In gastric cancer patients the increased expression of the Ia.7 determinant was most pronounced in advanced cancer (stage IVA and IVB). The increased expression of this determinant was related to the presence of the tumour as the number of MO expressing Ia.7 decreased 6 months following surgical resection of the tumour. Further, the increased expression of Ia.7 on MO correlated with the tumour infiltration of the serosa. The Ia.7 determinants were mainly expressed on MO which also expressed the receptor for the Fc part of immunoglobulin. Immunostaining in cellular infiltrates surrounding the tumour revealed that Ia.7+ macrophages (MO) were more numerous than in normal gastric mucosa and severe chronic gastritis and were mostly present in close proximity to tumour cells, while DR+MO were mainly localized within the stromal tissue of the tumour and their number was not increased in cancer infiltrates. These observations indicate that the Ia.7+ subpopulation of MO may be involved in the anti-tumour response of the host.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2458182     DOI: 10.1007/bf00200023

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  25 in total

1.  Association of colorectal tumor epithelium expressing HLA-D/DR with CD8-positive T-cells and mononuclear phagocytes.

Authors:  C A Allen; N Hogg
Journal:  Cancer Res       Date:  1987-06-01       Impact factor: 12.701

2.  The Fc receptors of normal and cancer patients monocytes.

Authors:  W Uracz; A Pituch-Noworolska; T Popiela; M Zembala
Journal:  Immunobiology       Date:  1982-12       Impact factor: 3.144

3.  Elevation of infiltrating mononuclear phagocytes in human colorectal tumors.

Authors:  C Allen; N Hogg
Journal:  J Natl Cancer Inst       Date:  1987-03       Impact factor: 13.506

4.  Differentiation of macrophages from Lewis lung carcinoma tumour cells in tissue sections by their alpha-naphthyl butyrate esterase activity.

Authors:  R Brown; M Wolman
Journal:  Histochem J       Date:  1981-11

5.  Induction of T cell responses in nonresponder mice by abolishing suppression with monoclonal antibodies recognizing A region-controlled, T cell-specific determinants.

Authors:  Z Ikezawa; M Nonaka; R Abe; T Tada; Z A Nagy; J Klein
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

6.  Recombinant interferon-gamma increases HLA-DR synthesis and expression.

Authors:  T Y Basham; T C Merigan
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

7.  Suppressor cells and survival of patients with advanced gastric cancer.

Authors:  M Zembala; B Mytar; I Ruggiero; W Uracz; T Popiela; A Czupryna
Journal:  J Natl Cancer Inst       Date:  1983-02       Impact factor: 13.506

8.  Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens.

Authors:  K Ozato; N Mayer; D H Sachs
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

9.  Clinicopathological staging of gastric cancer.

Authors:  J W Fielding; C Roginski; D J Ellis; B G Jones; J Powell; J A Waterhouse; V S Brookes
Journal:  Br J Surg       Date:  1984-09       Impact factor: 6.939

10.  "Activated" monocytes in gastric cancer patients. I. Increased Fc receptor expression, antibody-dependent cellular cytotoxicity and NBT reduction.

Authors:  W Uracz; A Pituch-Noworolska; M Zembala; T Popiela; A Czupryna
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

View more
  1 in total

1.  Recombinant interferon gamma up-regulates in vivo and down-regulates in vitro monocyte CD14 antigen expression in cancer patients.

Authors:  R Landmann; M Wesp; C Ludwig; R Obrist; C Knüsli; J P Obrecht
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.